Market Overview

Celsion Halted Wednesday, Says Will Host Conference Call Jan 31


Shares of Celsion (NASDAQ: CLSN) were halted in after-hours trading on Wednesday. The company said it would hold a conference call Thursday morning at 8 am to discuss the top-line results from its Phase III HEAT Study with ThermoDox.

The HEAT Study had received a Fast Track designation from the FDA and Orphan Drug status.

Posted-In: News FDA


Related Articles (CLSN)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Our Experts vs. S&P 500Powered by Benzinga
Marketfy Products Return S&P 500
Morning Profit Maker 42.72% 6.69%
The Option Prophet 91.14% 6.69%
SecretCaps 26.55% 6.69%
Short-Term Trend Trading 11.89% 6.69%
View the highest rated products→